These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 24963540)

  • 1. The ins and outs of microRNAs as biomarkers in liver disease and transplantation.
    Farid WR; Verhoeven CJ; de Jonge J; Metselaar HJ; Kazemier G; van der Laan LJ
    Transpl Int; 2014 Dec; 27(12):1222-32. PubMed ID: 24963540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation.
    Verhoeven CJ; Farid WR; de Ruiter PE; Hansen BE; Roest HP; de Jonge J; Kwekkeboom J; Metselaar HJ; Tilanus HW; Kazemier G; van der Laan LJ
    J Hepatol; 2013 Dec; 59(6):1231-8. PubMed ID: 23928409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?
    Gehrau RC; Mas VR; Maluf DG
    Expert Rev Gastroenterol Hepatol; 2013 Feb; 7(2):157-70. PubMed ID: 23363264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for hepatocellular carcinoma.
    Hemming AW; Nelson DR; Reed AI
    Minerva Chir; 2002 Oct; 57(5):575-85. PubMed ID: 12370659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression.
    Maluf DG; Archer KJ; Villamil F; Stravitz RT; Mas V
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):445-58. PubMed ID: 20678018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.
    Soga T; Sugimoto M; Honma M; Mori M; Igarashi K; Kashikura K; Ikeda S; Hirayama A; Yamamoto T; Yoshida H; Otsuka M; Tsuji S; Yatomi Y; Sakuragawa T; Watanabe H; Nihei K; Saito T; Kawata S; Suzuki H; Tomita M; Suematsu M
    J Hepatol; 2011 Oct; 55(4):896-905. PubMed ID: 21334394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs and long non-coding RNAs in liver surgery: Diagnostic and therapeutic merits.
    Hu ZQ; Lu Y; Cui D; Ma CY; Shao S; Chen P; Tao R; Wang JJ
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):218-228. PubMed ID: 32414577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. University of Modena experience in HIV-positive patients undergoing liver transplantation.
    Di Benedetto F; Tarantino G; De Ruvo N; Cautero N; Montalti R; Guerrini GP; Ballarin R; Spaggiari M; Smerieri N; Serra V; Rompianesi G; D'Amico G; Mimmo A; Iemmolo RM; Codeluppi M; Cocchi S; Guaraldi G; Gerunda GE
    Transplant Proc; 2011 May; 43(4):1114-8. PubMed ID: 21620066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrochimerism of donor type CD56+ CD3+ T cells in donor specific transfusion via portal vein following living related donor liver transplantation.
    Sato Y; Ichida T; Watanabe H; Yamamoto S; Abo T; Hatakeyama K
    Hepatogastroenterology; 2003; 50(54):2161-5. PubMed ID: 14696487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
    Zimmerman MA; Ghobrial RM; Tong MJ; Hiatt JR; Cameron AM; Hong J; Busuttil RW
    Arch Surg; 2008 Feb; 143(2):182-8; discussion 188. PubMed ID: 18283144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: a modelling approach.
    Deuffic-Burban S; Mathurin P; Rosa I; Bouvier AM; Cannesson A; Mourad A; Canva V; Louvet A; Deltenre P; Boleslawski E; Truant S; Pruvot FR; Dharancy S
    Dig Liver Dis; 2014 Feb; 46(2):157-63. PubMed ID: 24119483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation.
    Farid WR; Pan Q; van der Meer AJ; de Ruiter PE; Ramakrishnaiah V; de Jonge J; Kwekkeboom J; Janssen HL; Metselaar HJ; Tilanus HW; Kazemier G; van der Laan LJ
    Liver Transpl; 2012 Mar; 18(3):290-7. PubMed ID: 21932376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MicroRNAs in hepatocarcinogenesis].
    Lendvai G; Kiss A; Kovalszky I; Schaff Z
    Orv Hetil; 2012 Jun; 153(25):978-89. PubMed ID: 22714032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
    Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
    Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma.
    Li G; Cai G; Li D; Yin W
    Postgrad Med J; 2014 Feb; 90(1060):106-12. PubMed ID: 24243965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
    Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation in patients with hepatocellular carcinoma.
    Schwartz M
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S81-5. PubMed ID: 14762845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.